Clinical Trials

24 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06326268 2024-04-22

PHOTO-TREAT

30 enrolled

Lymphoma, Leukemia, Myeloid, Acute

NCT03455504 2024-04-10

V-FIRST

124 enrolled

Leukemia, Myeloid, Acute

NCT04460950 2024-04-10

Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms

237 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06349239 2024-04-05

ORAZ-351

100 enrolled

Leukemia, Myeloid, Acute

NCT04470947 2024-03-22

EXALT-2

150 enrolled

Leukemia, Lymphoma, Leukemia, Myeloid, Acute, Lymphoma, T-Cell

NCT03291444 2024-03-15

CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS

30 enrolled

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06285136 2024-02-29

Safety and Efficacy of Venetoclax Combination With Decitabine(DEC3-VEN) in the Treatment of AML in the Adult

Phase 2/3 Unknown

40 enrolled

Leukemia, Myeloid, Acute

NCT04330820 2024-02-28

RELAX

55 enrolled

Leukemia, Myeloid, Acute

NCT04021368 2024-02-14

RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome

112 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05641259 2024-02-02

A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML

198 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT04358393 2024-02-01

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

69 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT06234904 2024-01-31

Study of IBR733 Cell Injection in Acute Myeloid Leukemia

18 enrolled

Leukemia, Myeloid, Acute

NCT06218771 2024-01-23

A Study of TQB3454 Tablets in Patients With Blood Tumors

80 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04284228 2024-01-16

Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT

22 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04090268 2024-01-02

SportTherapy

380 enrolled

Adrenoleukodystrophy, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Motor Activity, Neoplasms, Sickle Cell Trait, Leukemia, B-Cell, Leukemia, T-Cell, Leukemia, Myeloid, Acute, beta-Thalassemia

NCT06162325 2023-12-08

Venetoclax in Combination With Standard Induction and Consolidation Chemotherapy in Newly Diagnosed Young AML Patients

Leukemia, Myeloid, Acute

NCT03896854 2023-11-29

CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

15 enrolled

Leukemia, Myeloid, Acute

NCT04257175 2023-11-28

CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression

Phase 2/3 Unknown

10 enrolled

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute

NCT04989335 2023-11-28

Bisantrene Combination for Resistant AML

29 enrolled

Leukemia, Myeloid, Acute

NCT05583175 2023-11-28

Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies

50 enrolled

Leukemia, Myeloid, Acute

NCT05918198 2023-11-21

Clinical Study of Venetoclax Combined With CAG in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia

52 enrolled

Leukemia, Myeloid, Acute

NCT06141304 2023-11-21

Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT

28 enrolled

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06105658 2023-10-30

Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML

20 enrolled

Leukemia, Myeloid, Acute

NCT04964518 2023-10-25

A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)

24 enrolled

Leukemia, Myeloid, Acute

NCT06073730 2023-10-10

Viale-a

Phase 3 Unknown

154 enrolled

Leukemia, Myeloid, Acute

NCT05801835 2023-09-21

A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection

36 enrolled

Leukemia, Myeloid, Acute

NCT06008405 2023-09-06

Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy

48 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05982756 2023-08-09

Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML

40 enrolled

Leukemia, Myeloid, Acute

NCT03867682 2023-08-04

Venetoclax and Lintuzumab-Ac225 in AML Patients

38 enrolled

Leukemia, Myeloid, Acute

NCT05005299 2023-08-01

VICTORY

LymphoidMyeloidOther hematologic neoplasmPlasma cell

18 enrolled

Graft vs Host Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05226468 2023-07-27

An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia

24 enrolled

Leukemia, Myeloid, Acute

NCT05951855 2023-07-19

Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients

42 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT05949762 2023-07-18

Safety and Efficacy of Venetoclax in Combination With Azacitidine and HA Regimen in the Treatment of AML in the Elderly

Phase EARLY_PHASE1 Unknown

Leukemia, Myeloid, Acute

NCT04923919 2023-07-13

Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Myeloid Leukemia

100 enrolled

Leukemia, Myeloid, Acute

NCT05919199 2023-06-26

FDG-PETAML

60 enrolled

Leukemia, Myeloid, Acute

NCT05893472 2023-06-08

A Study on the Efficacy and Safety of Venetoclax Combined With HAA Regimen in Newly Diagnosed Young AML.

Leukemia, Myeloid, Acute

NCT05264883 2023-05-30

Venetoclax+HMA+Aclarubicin Versus Venetoclax+HMA in Treatment-Naive Elderly Patients With AML

Phase 3 Unknown

170 enrolled

Leukemia, Myeloid, Acute

NCT05140811 2023-05-24

A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

126 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05471323 2023-05-19

Phase I Clinical Trial of RC1012 Injection in Patients With r/r AML

36 enrolled

Leukemia, Myeloid, Acute

NCT04471064 2023-05-18

A Study of XY0206 Tablets in Patients With Relapsed / Refractory Acute Myeloid Leukemia

60 enrolled

Leukemia, Myeloid, Acute

NCT05805072 2023-05-06

Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients

20 enrolled

Leukemia, Myeloid, Acute

NCT05823714 2023-04-21

Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT

70 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04265963 2023-04-18

CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT04272125 2023-04-18

Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia

40 enrolled

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT05697510 2023-04-06

SILTUXILAM

12 enrolled

Leukemia, Myeloid, Acute

NCT05503355 2023-04-04

A Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagnosed AML

80 enrolled

Leukemia, Myeloid, Acute

NCT05791890 2023-03-30

GilteRInf

78 enrolled

Infections, Leukemia, Myeloid, Acute

NCT02931942 2023-03-16

Changing Over Time of Ascorbic Acid After Chemotherapy